REPORT ID 6614

EMEA (Europe, Middle East and Africa) Low Molecular Weight Heparin Sodium Market Report 2017

Publish Date
26-Dec-17
Pages
102
Format
Electronic (PDF)

In this report, the EMEA Low Molecular Weight Heparin Sodium market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Low Molecular Weight Heparin Sodium for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Low Molecular Weight Heparin Sodium market competition by top manufacturers/players, with Low Molecular Weight Heparin Sodium sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Aspen
    Sanofi-aventis
    Pfizer
    Opocrin
    CSBIO
    Dongying Tiandong Pharmaceutica
    Changzhou Qianhong Bio-pharma
    Techdow
    Yantai Dongcheng Pharmaceutical Group

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Enoxaparin
    Dalteparin
    Tinzaparin
    Fraxiparine

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Medical
    Research

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Low Molecular Weight Heparin Sodium Market Report 2017
1 Low Molecular Weight Heparin Sodium Overview
    1.1 Product Overview and Scope of Low Molecular Weight Heparin Sodium
    1.2 Classification of Low Molecular Weight Heparin Sodium
        1.2.1 EMEA Low Molecular Weight Heparin Sodium Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Low Molecular Weight Heparin Sodium Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Enoxaparin
        1.2.4 Dalteparin
        1.2.5 Tinzaparin
        1.2.6 Fraxiparine
    1.3 EMEA Low Molecular Weight Heparin Sodium Market by Application/End Users
        1.3.1 EMEA Low Molecular Weight Heparin Sodium Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Medical
        1.3.3 Research
    1.4 EMEA Low Molecular Weight Heparin Sodium Market by Region
        1.4.1 EMEA Low Molecular Weight Heparin Sodium Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Low Molecular Weight Heparin Sodium (2012-2022)
        1.5.1 EMEA Low Molecular Weight Heparin Sodium Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Low Molecular Weight Heparin Sodium Revenue and Growth Rate (2012-2022)

2 EMEA Low Molecular Weight Heparin Sodium Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Low Molecular Weight Heparin Sodium Market Competition by Players/Manufacturers
        2.1.1 EMEA Low Molecular Weight Heparin Sodium Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Low Molecular Weight Heparin Sodium Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Low Molecular Weight Heparin Sodium Sale Price by Players (2012-2017)
    2.2 EMEA Low Molecular Weight Heparin Sodium (Volume and Value) by Type/Product Category
        2.2.1 EMEA Low Molecular Weight Heparin Sodium Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Low Molecular Weight Heparin Sodium Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Low Molecular Weight Heparin Sodium Sale Price by Type (2012-2017)
    2.3 EMEA Low Molecular Weight Heparin Sodium (Volume) by Application
    2.4 EMEA Low Molecular Weight Heparin Sodium (Volume and Value) by Region
        2.4.1 EMEA Low Molecular Weight Heparin Sodium Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Low Molecular Weight Heparin Sodium Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Low Molecular Weight Heparin Sodium Sales Price by Region (2012-2017)

3 Europe Low Molecular Weight Heparin Sodium (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Low Molecular Weight Heparin Sodium Sales and Value (2012-2017)
        3.1.1 Europe Low Molecular Weight Heparin Sodium Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Low Molecular Weight Heparin Sodium Revenue and Growth Rate (2012-2017)
    3.2 Europe Low Molecular Weight Heparin Sodium Sales and Market Share by Type
    3.3 Europe Low Molecular Weight Heparin Sodium Sales and Market Share by Application
    3.4 Europe Low Molecular Weight Heparin Sodium Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Low Molecular Weight Heparin Sodium Sales Volume by Countries (2012-2017)
        3.4.2 Europe Low Molecular Weight Heparin Sodium Revenue by Countries (2012-2017)
        3.4.3 Germany Low Molecular Weight Heparin Sodium Sales and Growth Rate (2012-2017)
        3.4.4 France Low Molecular Weight Heparin Sodium Sales and Growth Rate (2012-2017)
        3.4.5 UK Low Molecular Weight Heparin Sodium Sales and Growth Rate (2012-2017)
        3.4.6 Russia Low Molecular Weight Heparin Sodium Sales and Growth Rate (2012-2017)
        3.4.7 Italy Low Molecular Weight Heparin Sodium Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Low Molecular Weight Heparin Sodium Sales and Growth Rate (2012-2017)

4 Middle East Low Molecular Weight Heparin Sodium (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Low Molecular Weight Heparin Sodium Sales and Value (2012-2017)
        4.1.1 Middle East Low Molecular Weight Heparin Sodium Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Low Molecular Weight Heparin Sodium Revenue and Growth Rate (2012-2017)
    4.2 Middle East Low Molecular Weight Heparin Sodium Sales and Market Share by Type
    4.3 Middle East Low Molecular Weight Heparin Sodium Sales and Market Share by Application
    4.4 Middle East Low Molecular Weight Heparin Sodium Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Low Molecular Weight Heparin Sodium Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Low Molecular Weight Heparin Sodium Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Low Molecular Weight Heparin Sodium Sales and Growth Rate (2012-2017)
        4.4.4 Israel Low Molecular Weight Heparin Sodium Sales and Growth Rate (2012-2017)
        4.4.5 UAE Low Molecular Weight Heparin Sodium Sales and Growth Rate (2012-2017)
        4.4.6 Iran Low Molecular Weight Heparin Sodium Sales and Growth Rate (2012-2017)

5 Africa Low Molecular Weight Heparin Sodium (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Low Molecular Weight Heparin Sodium Sales and Value (2012-2017)
        5.1.1 Africa Low Molecular Weight Heparin Sodium Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Low Molecular Weight Heparin Sodium Revenue and Growth Rate (2012-2017)
    5.2 Africa Low Molecular Weight Heparin Sodium Sales and Market Share by Type
    5.3 Africa Low Molecular Weight Heparin Sodium Sales and Market Share by Application
    5.4 Africa Low Molecular Weight Heparin Sodium Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Low Molecular Weight Heparin Sodium Sales Volume by Countries (2012-2017)
        5.4.2 Africa Low Molecular Weight Heparin Sodium Revenue by Countries (2012-2017)
        5.4.3 South Africa Low Molecular Weight Heparin Sodium Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Low Molecular Weight Heparin Sodium Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Low Molecular Weight Heparin Sodium Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Low Molecular Weight Heparin Sodium Sales and Growth Rate (2012-2017)

6 EMEA Low Molecular Weight Heparin Sodium Manufacturers/Players Profiles and Sales Data
    6.1 Aspen
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Low Molecular Weight Heparin Sodium Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Aspen Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sanofi-aventis
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Low Molecular Weight Heparin Sodium Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sanofi-aventis Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Pfizer
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Low Molecular Weight Heparin Sodium Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Pfizer Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Opocrin
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Low Molecular Weight Heparin Sodium Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Opocrin Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 CSBIO
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Low Molecular Weight Heparin Sodium Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 CSBIO Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Dongying Tiandong Pharmaceutica
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Low Molecular Weight Heparin Sodium Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Changzhou Qianhong Bio-pharma
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Low Molecular Weight Heparin Sodium Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Techdow
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Low Molecular Weight Heparin Sodium Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Techdow Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Yantai Dongcheng Pharmaceutical Group
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Low Molecular Weight Heparin Sodium Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Low Molecular Weight Heparin Sodium Manufacturing Cost Analysis
    7.1 Low Molecular Weight Heparin Sodium Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Low Molecular Weight Heparin Sodium

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Low Molecular Weight Heparin Sodium Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Low Molecular Weight Heparin Sodium Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Low Molecular Weight Heparin Sodium Market Forecast (2017-2022)
    11.1 EMEA Low Molecular Weight Heparin Sodium Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Low Molecular Weight Heparin Sodium Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Low Molecular Weight Heparin Sodium Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Low Molecular Weight Heparin Sodium Price and Trend Forecast (2017-2022)
    11.2 EMEA Low Molecular Weight Heparin Sodium Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Low Molecular Weight Heparin Sodium Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Low Molecular Weight Heparin Sodium Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Low Molecular Weight Heparin Sodium Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Low Molecular Weight Heparin Sodium Sales Forecast by Type (2017-2022)
    11.7 EMEA Low Molecular Weight Heparin Sodium Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer